Retraction

Risk-Associated Long Noncoding RNA FOXD3-AS1 Inhibits Neuroblastoma Progression by Repressing PARP1-Mediated Activation of CTCF

Paper Information

Record ID:
44550
Author(s):
Xiang Zhao
Dan Li
Dandan Huang
Huajie Song
Hong Mei
Erhu Fang
Xiaojing Wang
Feng Yang
Liduan Zheng
Kai Huang
Qiangsong Tong
Journal:
Molecular Therapy ( Elsevier - Cell Press )
Publication Date:
December 22, 2017
Retraction Date:
May 11, 2023 (2.5 years years ago)
Subjects:
Broad Categories:
Biology Genetics
Institutions:
Country:
🇨🇳 China
Article Type:
Research Article
Publisher:
Elsevier - Cell Press
Open Access:
Yes
DOI:
10.1016/j.ymthe.2017.12.017
PubMed ID:
29398485
Retraction PubMed ID:
37172590

Retraction Details

Retraction Reasons:
Nature of Retraction:

Retraction

Retraction Notice:
10.1016/j.ymthe.2023.05.001

Citations (63)

63
Total Citations
6
Post-Retraction
(9.5%)
57
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
1 Within 30 days
6 Within 1 year
0 After 2+ years
295 Days since retraction (latest)
<scp>RPL35A</scp> drives ovarian cancer progression by promoting the binding of <scp>YY1</scp> to <scp>CTCF</scp> promoter
Huijuan Wu, Liangbin Xia, Lu Sun et al. (9 authors)
Journal of Cellular and Molecular Medicine Open Access
Published: Mar 2024
4 citations
295 days after retraction
Stabilization of KPNB1 by deubiquitinase USP7 promotes glioblastoma progression through the YBX1-NLGN3 axis
Jie Li, Bin Zhang, Zishan Feng et al. (20 authors)
Journal of Experimental & Clinical Cancer Research Open Access
Published: Jan 2024
7 citations
257 days after retraction
LncRNA ZNF674-AS1 drives cell growth and inhibits cisplatin-induced pyroptosis via up-regulating CA9 in neuroblastoma
Kunming Zhao, Xinyi Wang, Yaqiong Jin et al. (12 authors)
Cell Death and Disease Open Access
Published: Jan 2024
10 citations
238 days after retraction
Neuroblastoma Epigenetic Landscape: Drugging Opportunities
Veronica Veschi, Kaat Durinck, Carol J. Thiele et al. (4 authors)
Pediatric oncology
Published: Jan 2024
1 citation
235 days after retraction
Reduction of GAS5 and FOXD3-AS1 long non-coding RNAs in patients with bipolar disorder
Bita Zamani, Mahdieh Mehrab Mohseni, Bahar Naghavi Gargari et al. (6 authors)
Scientific Reports Open Access
Published: Aug 2023
4 citations
105 days after retraction
Targeting long noncoding RNAs in neuroblastoma: Progress and prospects
Ali Ataei, Mahsa Tahsili, Golsa Hayadokht et al. (9 authors)
Chemical Biology & Drug Design
Published: Jun 2023
2 citations
28 days after retraction
MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cells
Faezeh Tolue Ghasaban, Amirhosein Maharati, Iman Akhlaghipour et al. (4 authors)
Cancer Cell International Open Access
Published: Apr 2023
16 citations
16 days before retraction
Therapeutic targeting of CNBP phase separation inhibits ribosome biogenesis and neuroblastoma progression via modulating SWI/SNF complex activity
Anpei Hu, Guo Chen, Banghe Bao et al. (14 authors)
Clinical and Translational Medicine Open Access
Published: Apr 2023
10 citations
40 days before retraction
Roles of lncRNAs in childhood cancer: Current landscape and future perspectives
Fei Liu, Qian-Wen Xiong, Jinhu Wang et al. (4 authors)
Frontiers in Oncology Open Access
Published: Feb 2023
9 citations
73 days before retraction
Neuroblastoma
Ellen King, Nadiya Bayeva, Raymond L. Stallings et al. (4 authors)
Elsevier eBooks
Published: Jan 2023
130 days before retraction
Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification
Xiaofeng Liu, Wenyan Chen, Yu Qi et al. (4 authors)
Evidence-based Complementary and Alternative Medicine Open Access
Published: Sep 2022
6 citations
239 days before retraction
Multimolecular characteristics of cell-death related hub genes in human cancers: a comprehensive pan-cancer analysis
Dingtao Hu, Tingyu Zhang, Ziye Yan et al. (14 authors)
Cell Cycle Open Access
Published: Jul 2022
2 citations
297 days before retraction
LncRNA FOXD3-AS1 promotes breast cancer progression by mediating ARF6
Xingxing Zhang, Xiaojun Zhao, Lihua Chang et al. (6 authors)
Breast Cancer
Published: Jun 2022
10 citations
336 days before retraction
Exosomal CTCF Confers Cisplatin Resistance in Osteosarcoma by Promoting Autophagy via the IGF2-AS/miR-579-3p/MSH6 Axis
Haibo Zhan, Jun Xiao, Po Wang et al. (11 authors)
Journal of Oncology Open Access
Published: May 2022
15 citations
345 days before retraction
LINC00839 Promotes Neuroblastoma Progression by Sponging miR-454-3p to Up-Regulate NEUROD1
Qian Zhang, Jingli Wei, Na Li et al. (4 authors)
Neurochemical Research
Published: May 2022
12 citations
353 days before retraction
LncRNAs and CircRNAs in cancer
Xin Yin, Huiran Lin, Lei Lin et al. (6 authors)
MedComm Open Access
Published: May 2022
25 citations
364 days before retraction
The role of ncRNAs in neuroblastoma: mechanisms, biomarkers and therapeutic targets
Shaohui Huang, Naying Gong, Jiangbin Li et al. (7 authors)
Biomarker Research Open Access
Published: Apr 2022
9 citations
399 days before retraction
HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation
Huajie Song, Jianqun Wang, Xiaojing Wang et al. (15 authors)
Oncogene
Published: Mar 2022
23 citations
415 days before retraction
Emerging Roles and Mechanisms of lncRNA FOXD3-AS1 in Human Diseases
Qinfan Yao, Xiuyuan Zhang, Dajin Chen
Frontiers in Oncology Open Access
Published: Feb 2022
11 citations
440 days before retraction
Diagnostic value of long noncoding RNA LINC01485 in patients with colorectal cancer
Zuojian Hu, Junrong Wu, Shaolin Tan et al. (9 authors)
Clinical Biochemistry
Published: Jan 2022
3 citations
483 days before retraction
Potential clinical application of lncRNAs in pediatric cancer
Ravindresh Chhabra, Priyasha Neyol, Sonali Bazala et al. (8 authors)
Elsevier eBooks
Published: Jan 2022
1 citation
495 days before retraction
LncRNA FOXD3-AS1 Promotes Tumorigenesis of Glioma via Targeting miR-128-3p/SZRD1 Axis
Zhang Li, Ming Li, Pengcheng Xia et al. (5 authors)
Cancer Management and Research Open Access
Published: Dec 2021
3 citations
526 days before retraction
Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency
Jeffrey R. Haswell, Kaia Mattioli, Chiara Gerhardinger et al. (10 authors)
PLoS ONE Open Access
Published: Nov 2021
25 citations
554 days before retraction
Therapeutic targeting of <i>SPIB</i>/<i>SPI1</i>‐facilitated interplay of cancer cells and neutrophils inhibits aerobic glycolysis and cancer progression
Jianqun Wang, Xiaojing Wang, Yanhua Guo et al. (13 authors)
Clinical and Translational Medicine Open Access
Published: Nov 2021
39 citations
556 days before retraction
Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance
Guangxian Mao, Zhimin Mu, Da Wu
Acta Biochimica et Biophysica Sinica Open Access
Published: Sep 2021
51 citations
610 days before retraction
Adipose-derived stem cell-derived extracellular vesicles inhibit neuroblastoma growth by regulating GABBR1 activity through LINC00622-mediated transcription factor AR
Mengguo Guo, Dongpeng Li, Yawen Feng et al. (5 authors)
Journal of Leukocyte Biology
Published: Aug 2021
15 citations
622 days before retraction
Long noncoding RNA differentiation antagonizing nonprotein coding RNA promotes the proliferation, invasion and migration of neuroblastoma cells via targeting β-1, 4-galactosyltransferase III by sponging miR-338-3p
Chunhua Bi, Jili Shan, Maoxiang Li et al. (7 authors)
Neuroreport
Published: May 2021
7 citations
714 days before retraction
Development and Validation of a Lncrnas-Based Nomogram for Survival Prediction in Neuroblastoma Patients
Yong Lv, Shuguang Jin, Bo Xiang
Research Square (Research Square) Open Access
Published: May 2021
734 days before retraction
An Overview of Long Non-Coding (lnc)RNAs in Neuroblastoma
Francesca Baldini, Matilde Calderoni, Laura Vergani et al. (6 authors)
International Journal of Molecular Sciences Open Access
Published: Apr 2021
13 citations
752 days before retraction
The PARP Way to Epigenetic Changes
Simone Ummarino, Clinton Hausman, Annalisa Di Ruscio
Genes Open Access
Published: Mar 2021
25 citations
782 days before retraction
FOXD3‑AS1/miR‑128‑3p/LIMK1 axis regulates cervical cancer progression
Xiufang Yang, Huilan Du, Wenhui Bian et al. (5 authors)
Oncology Reports Open Access
Published: Mar 2021
19 citations
786 days before retraction
Non-Coding RNAs Participate in the Pathogenesis of Neuroblastoma
Omidvar Rezaei, Kasra Honarmand Tamizkar, Mohammadreza Hajiesmaeili et al. (5 authors)
Frontiers in Oncology Open Access
Published: Feb 2021
8 citations
806 days before retraction
Non-Coding RNAs in Retinoic Acid as Differentiation and Disease Drivers
Carlos García‐Padilla, Estefanía Lozano-Velasco, Carmen López‐Sánchez et al. (6 authors)
Non-Coding RNA Open Access
Published: Feb 2021
5 citations
813 days before retraction
Genome-wide CRISPR interference screen identifies long non-coding RNA loci required for differentiation and pluripotency
Jeffrey R. Haswell, Kaia Mattioli, Chiara Gerhardinger et al. (9 authors)
bioRxiv (Cold Spring Harbor Laboratory) Open Access
Published: Feb 2021
3 citations
822 days before retraction
LncRNA FOXD3-AS1 knockdown protects against cerebral ischemia/reperfusion injury via miR-765/BCL2L13 axis
Yi Lü, Han Yao, Jinlin He et al. (6 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Oct 2020
34 citations
939 days before retraction
LINC01089 inhibits the progression of cervical cancer via inhibiting miR‐27a‐3p and increasing BTG2
Shuoxi Li, Yu Han, Xue-Song Liang et al. (4 authors)
The Journal of Gene Medicine
Published: Oct 2020
23 citations
946 days before retraction
FOXD3-AS1 suppresses the progression of non-small cell lung cancer by regulating miR-150/SRCIN1axis
Tao Ji, Yanan Zhang, Zheng Wang et al. (6 authors)
Cancer Biomarkers
Published: Sep 2020
11 citations
975 days before retraction
Emerging therapeutic targets for neuroblastoma
Natarajan Aravindan, Terence S. Herman, Sheeja Aravindan
Expert Opinion on Therapeutic Targets Open Access
Published: Sep 2020
22 citations
982 days before retraction
&lt;p&gt;LncRNA DLX6-AS1 Promotes the Progression of Neuroblastoma by Activating STAT2 via Targeting miR-506-3p&lt;/p&gt;
Yanping Hu, Huifang Sun, Jiting Hu et al. (4 authors)
Cancer Management and Research Open Access
Published: Aug 2020
22 citations
1013 days before retraction
Association of lncRNA SH3PXD2A-AS1 with preeclampsia and its function in invasion and migration of placental trophoblast cells
Qian Chen, Sijia Jiang, Haihua Liu et al. (12 authors)
Cell Death and Disease Open Access
Published: Jul 2020
43 citations
1018 days before retraction
Determination of long non‑coding RNAs associated with EZH2 in neuroblastoma by RIP‑seq, RNA‑seq and ChIP‑seq
Mujie Ye, Lulu Xie, Jingjing Zhang et al. (8 authors)
Oncology Letters Open Access
Published: Jul 2020
25 citations
1032 days before retraction
An Artificial CTCF Peptide Triggers Efficient Therapeutic Efficacy in Ocular Melanoma
Xuyang Wen, Huixue Wang, Peiwei Chai et al. (10 authors)
Molecular Therapy — Oncolytics Open Access
Published: Jul 2020
4 citations
1036 days before retraction
LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p
Baiqi Wang, Lili Xu, Ju Zhang et al. (7 authors)
Biomedicine & Pharmacotherapy Open Access
Published: Jun 2020
43 citations
1058 days before retraction
<i>FOXD3-AS1</i> Contributes to the Progression of Melanoma Via <i>miR-127-3p/FJX1</i> Axis
Neng Wan, Weixi Yang, Hongyu Cheng et al. (4 authors)
Cancer Biotherapy and Radiopharmaceuticals
Published: May 2020
9 citations
1105 days before retraction
Linc-FOXD3 knockdown enhances hippocampal NSCs activation through upregulation of the Wnt/β-catenin pathway
Haili Lang, Renjie Xiao, Ying Li et al. (7 authors)
Neuroscience Letters
Published: Apr 2020
4 citations
1114 days before retraction
Identification of prognostic long noncoding RNAs associated with spontaneous regression of neuroblastoma
Xinyao Meng, Erhu Fang, Xiang Zhao et al. (4 authors)
Cancer Medicine Open Access
Published: Mar 2020
23 citations
1141 days before retraction
RETRACTED ARTICLE: HNF4A-AS1/hnRNPU/CTCF axis as a therapeutic target for aerobic glycolysis and neuroblastoma progression
Huajie Song, Dan Li, Xiaojing Wang et al. (14 authors)
Journal of Hematology & Oncology Open Access
Published: Mar 2020
59 citations
1141 days before retraction
LncRNA FOXD3-AS1 Mediates AKT Pathway to Promote Growth and Invasion in Hepatocellular Carcinoma Through Regulating RICTOR
Chao Liu, Meng Zhang, Jisen Zhao et al. (8 authors)
Cancer Biotherapy and Radiopharmaceuticals
Published: Mar 2020
13 citations
1148 days before retraction
Association of<i>PARP1</i>polymorphisms with response to chemotherapy in patients with high‐risk neuroblastoma
Marianna Avitabile, Vito Alessandro Lasorsa, Sueva Cantalupo et al. (14 authors)
Journal of Cellular and Molecular Medicine Open Access
Published: Feb 2020
14 citations
1169 days before retraction
LncRNA SNHG4 promotes neuroblastoma proliferation, migration, and invasion by sponging miR-377-3p
Hui Yang, Jian Guo, Minjia Zhang et al. (4 authors)
Neoplasma Open Access
Published: Jan 2020
23 citations
1226 days before retraction
Quick Stats
Total Citations: 63
Years Since Retraction: 2.5 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
miR-129-2-3p inhibits colon cancer cell proliferation by do…
Arab Journal of Gastroenterology • 12 citations
Lentivirus Mediated Delivery of Neurosin Promotes Clearance…
Molecular Therapy • 71 citations
ESCRT-mediated Uptake and Degradation of Brain-targeted α-s…
Molecular Therapy • 83 citations
Hypoxia-induced lncHILAR promotes renal cancer metastasis v…
Molecular Therapy • 73 citations
The Predictive Efficacy of Programmed Cell Death in Immunot…
Environmental Toxicology • 6 citations
Actions
More from this journal Similar subjects View Original Paper View Retraction Notice